MedPath

Efficacy of transcranial magnetic stimulation in Parkinsons Disease

Not Applicable
Conditions
Health Condition 1: null- Parkinsons DiseaseHealth Condition 2: G20- Parkinsons disease
Registration Number
CTRI/2017/07/009064
Lead Sponsor
All India Institute Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosis of clinically definite PD, defined by UKPD brain bank clinical and diagnostic criteria. With presence of at least 1 out of 3 cardinal motor features of PD (resting tremor, rigidity, and postural impairment like bradykinesia);

2.PD patients of both gender with H&Y stage from 1 to 3.

3.PD patients between age 45 to 85 on stable medication for at least 30 days.

Exclusion Criteria

Subjects with any other neurological, psychiatric co-morbidities were excluded from the study. Hypertensives and diabetics were included only if they were stable on antihypertensives and oral hypoglycaemics for past 6 months from the time of enrollment. Also subjects with any ferromagnetic implants or dental fillings were excluded so were the subjects who were eligible for deep brain stimulation (DBS) and were scheduled to undergo surgery in next 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i.To compare the status of cortical plasticity between all the three treatment groups (M1, PM, SMA) using fMRI and FDG-PET. <br/ ><br>ii.To compare the clinical condition of the patients in the three treatment groups on the basis of UPDRS, H & Y scale, PDQ-39, HAM-A, HAM-D, HADS and CGI. <br/ ><br>iii.To compare the motor performance of the patient using Purdue peg-board test, and Timed motor tests. <br/ ><br>Timepoint: Baseline 0 day <br/ ><br>Post Sham at 4th week <br/ ><br>Post Real at 8th week <br/ ><br>[Baseline:-After recruitment <br/ ><br>Post-Sham:-After 4 sessions of Sham TMS <br/ ><br>Post-Real:- After 4 sessions of Real TMS.] <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.To compare the clinical condition of the patients in the three treatment groups on the basis of UPDRS, H & Y scale, PDQ-39, HAM-A, HAM-D, and CGI. <br/ ><br>2.To compare the motor performance of the patient using Purdue peg-board test, and Timed motor tests. <br/ ><br>Timepoint: Baseline 0 day <br/ ><br>Post Sham at 4th week <br/ ><br>Post Real at 8th week <br/ ><br>[Baseline:-After recruitment <br/ ><br>Post-Sham:-After 4 sessions of Sham TMS <br/ ><br>Post-Real:- After 4 sessions of Real TMS.]
© Copyright 2025. All Rights Reserved by MedPath